ICP
INSM icon

Interchange Capital Partners’s Insmed INSM Stock Holding History

Interchange Capital Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-71
Closed -$2K – 649
2020
Q4 		$2K Buy
+71
New +$2.59K ﹤0.01% 1086

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Interchange Capital Partners's INSM Position: Q1 2021 in Review

Interchange Capital Partners sold out of Insmed (INSM) in Q1 2021, closing a stake of 71 shares — an estimated $2K sold.

Interchange Capital Partners first reported a position in INSM in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 199 funds tracked by Wall St. Rank hold INSM as of Q1 2021.

  • Interchange Capital Partners reported no remaining Insmed position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 71 Insmed shares in Q1 2021, an estimated $2K.
  • Interchange Capital Partners first reported a position in Insmed in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's Insmed position peaked at $2K in Q4 2020.
  • 199 funds tracked by Wall St. Rank held Insmed as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.